Publications

Smerbeck A, Olsen L, Morra LF, Raines J, Schretlen DJ, Benedict RHB.  (2023).  Effects of Repeated Administration and Comparability of Alternate Forms for the Global Neuropsychological Assessment (GNA).  Assessment, 30:160-170.

Fuchs TA, Gillies J, Jaworski MG, Wilding M, Youngs M, Weinstock-Guttman B, Benedict RHB.  (2022).  Repeated forms, testing intervals, and SDMT performance in a large multiple sclerosis dataset.  Multiple Sclerosis and Related Disorders. 68:104375. doi: 10.1016/j.msard.2022.104375

Motl RW, Sandroff BM, Benedict RHB.  (2022).  Moderate-to-vigorous physical activity is associated with processing speed, but not learning and memory, in cognitively impaired persons with multiple sclerosis.  Multiple Sclerosis and Related Disorders, 63:103833.

Fuchs TA, Schoonheim MM, Broeders TAA, Hulst HE, Weinstock-Guttman B, Jakimovski D, Silver J, Zivadinov R, Geurts JJG, Dwyer MG, Benedict RHB.  (2022).  Functional network dynamics and decreased conscientiousness in multiple sclerosis.  J Neurology, 269:2696-2706.  

Fuchs TA, Jaworski MG, Youngs MU, Abdel-Kerim O, Wojcik C, Weinstock-Guttman B, Benedict RHB.  (2022).  Preliminary Support of a Behavioral Intervention for Trait Conscientiousness in Multiple Sclerosis.  International Journal of MS Care, 24:45-53.

Cohan SL, Benedict RHB, Cree BAC, DeLuca J, Hua LH, Chun J.  (2022).  The Two Sides of Siponimod: Evidence for Brain and Immune Mechanisms in Multiple Sclerosis.  CNS Drugs, 36:703-719.

Sandroff B, Motl RW, Roman CAF, Wylie GR, DeLuca J, Cutter GR, Benedict RHB, Dwyer MG, Zivadinov R.  (2022).  Thalamic atrophy moderates associations among aerobic fitness, cognitive processing speed, and walking endurance in persons with multiple sclerosis.  Journal of Neurology, 269:5531-5540.

Weinstock Z, Morrow S, Conway D, Fuchs TA, Wojcik C, Unverdi M, Zivadinov R, Weinstock-Guttman B, Iverson GL, Dwyer MG, Benedict RHB.  (2022).  Interpreting change on the Symbol Digit Modalities Test in people with relapsing multiple sclerosis using the reliable change methodology.  Multiple Sclerosis Journal, 28:1101-1111.

Olson LT, Smerbeck A, Figueroa CM, Raines JM, Szigeti K, Schretlen DJ, Benedict RHB.  (2022).  Preliminary validation of the Global Neuropsychological Assessment in Alzheimer’s disease and healthy volunteers.  Assessment, 29:817-825.  

Benedict RHB, Tomic D, Cree BA, Fox R, Giovannoni G, Bar-Or A, Gold R, Vermersch P, Pohlmann H, Wright I, Karlsson G, Dahlke F, Wolf C, Kappos L.  (2021).  Siponimod and cognition in secondary progressive multiple sclerosis: EXPAND secondary analyses.  Neurology, 96:376-386.

Bergsland N, Benedict RHB, Dwyer MG, Fuchs TA, Jakimovski D, Schweser F, Tavazzi E, Weinstock-Guttman B, Zivadinov R.  (2021).  Thalamic nuclei volumes and their relationships to neuroperformance in multiple sclerosis: A cross-sectional structural MRI study.  J Magnetic Resonance Imaging, 53:731-739.

Jaworski MG, Fuchs TA, Dwyer MG, Wojcik C, Zivadinov R, Weinstock-Guttman B, Benedict RHB.  (2021).  Conscientiousness and deterioration in employment status in multiple sclerosis over 3 years.  Multiple Sclerosis Journal, 27:1125_1135.

Vanotti S, Eizaguirre MB, Ciufia NP, Yastremiz CM, Roman MS, Canyazo CM, Alonso R, Garcea O, Benedict RHB, Caceres F.  (2021).  Employment status monitoring in an Argentinian population of patients with multiple sclerosis: Particularities of a developing country.  Work, 68:1121-1131.

Fuchs TA, Wojcik C, Wilding GE, Pol J, Dwyer MG, Weinstock-Guttman B, Zivadinov R, Benedict RHB. (2020).    Trait Conscientiousness predicts rate of longitudinal SDMT decline in multiple sclerosis.  Multiple Sclerosis Journal, 26:245-252.

Fuchs TA, Benedict RHB, Wilding GE, Wojcik C, Jakimovski D, Bergsland N, Ramasmy DP, Weinstock-Guttman B, Zivadinov R, Dwyer MG. (2020).   Trait Conscientiousness predicts rate of brain atrophy in multiple sclerosis.  Multiple Sclerosis Journal, 26:1433-1436.

Wojcik CM, Rao SM, Schembri AJ, Drake AS, Maruff P, Schindler D, Alberts J, Yasin F, Pol J, Weinstock-Guttman B, Benedict RHB.  (2020).  Necessity of technicians for computerized neuropsychological assessment devices in multiple sclerosis.  Multiple Sclerosis Journal, 26:109-113.

Jakimovski D, Szigeti K, Jaworski M, Ouf A, Weinstock-Gutman B, Zivadinov R, Benedict RHB.  (2020).  Differential diagnosis of cognitive decline in elderly individuals with multiple sclerosis.  Cognitive Behavioral Neurology, 33:294-300.

Jakimovski D, Bergsland N, Dwyer MG, Hagemeier J, Ramasamy DP, Szigeti K, Guttuso T, Lichter D, Hojnacki D, Weinstock-Guttman B, Benedict RHB, Zivadinov R.  (2020).  Long-standing multiple sclerosis neurodegeneration: volumetric magnetic resonance imaging comparison to Parkinson’s disease, mild cognitive impairment, Alzheimer’s disease, and elderly healthy controls.  Neurobiology of Aging, 90:84-92.

Jakimovski D, Bergsland N, Dwyer MG, Traversone J, Hagemeier J, Fuchs TA, Ramasamy DP, Weinstock-Guttman B, Benedict RHB, Zivadinov R.  (2020).  Cortical and deep gray matter perfusion associations with physical and cognitive performance in multiple sclerosis patients.  Front Neurol, 11:700.

Benedict RHB.  Cognition in multiple sclerosis: Charcot was right.  (2020).  Lancet Neurology, 19:810.

Benedict RHB, Amato MP, DeLuca J, Geurts JJG.  (2020).  Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues.  Lancet Neurology, 19:860-871.

Fuchs TA, Benedict RHB, Bartnik A, Choudhery S, Li X, Mallory M, Oship D, Yasin F, Ashton K, Jakimovski D, Bergsland N, Ramasamy D, Weinstock-Guttman B, Zivadinov R, Dwyer MG.  (2019).  Preserved network functional connectivity underlies cognitive reserve in multiple sclerosis.  Human Brain Mapping, 40:5231-5241.

Jakimovski D, Weinstock-Guttman B, Roy S, Jaworski M, Hancock L, Nizinski A, Srinivasan P, Fuchs TA, Szigeti K, Zivadinov R, Benedict RHB.  (2019).  Cognitive profiles of aging in multiple sclerosis.  Frontiers Aging Neuroscience, 11:105.

Wojcik CM, Beier M, Costello K, DeLuca J, Feinstein A, Goverover Y, Gudesblatt M, Jaworski M, Kalb R, Kostich L, LaRocca NG, Rodgers JD, Benedict RHB.  (2019).  Computerized neuropsychological assessment devices in multiple sclerosis: A systematic review.  Multiple Sclerosis Journal, 25:1848-1869. 

Chapman B, Lin F, Roy S, Benedict RHB, Lyness JM.  (2019).  Health risk prediction models incorporating personality data: Motivation, challenges, and illustration.  Personality Disorders: Theory, Research, and Treatment, 10:46-58.

Barcellos LF, Bellesis KH, Shen L, Shao X, Chinn T, Frndak S, Drake A, Bakshi N, Marcus J, Schaefer C, Benedict RHB.  (2018).  Remote assessment of verbal memory in MS patients using the California Verbal Learning Test.  Multiple Sclerosis Journal, 24:354-357.

Smerbeck A, Benedict RHB, Eshaghi A, Vanotti S, Spedo C, Blahova Dusankova J, Sahraian MA, Marques VD, Langdon D.  (2018).  Influence of nationality on the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS).  Clinical Neuropsychologist, 32:54-62.

Chapman BP, Benedict RHB, VanKee L, Roy, Szigeti, K, Federoff H, Mapstone M.  (2018).  Apolipoprotein E genotype impact on memory and attention in older persons: The moderating role of personality phenotype.  International Journal of Geriatric Psychiatry, 33:332-339.

Rocca MA, Battaglini M, Benedict RHB, De Stefano N, Geurts JJ, Henry RG, Horsfield MA, Jenkinson M, Pagani E, Filippi M.  (2017).   Brain MRI atrophy quantification in MS: From methods to clinical application.  Neurology, 88:403-413.  

Frndak, Smerbeck AM, Irwin LN, Drake AS, Kordovski VM, Kunker KA, Khan AL, Benedict RHB.  (2016).  Latent profile analysis of regression-based norms demonstrates relationship of compounding MS symptom burden and negative work events.  Clinical Neuropsychologist, 30:1050-1062.

Benedict RHB, DeLuca J, Phillips G, LaRocca N, Hudson LD, Rudick R, and the Multiple Sclerosis Outcomes Assessment Consortium.  (2017).  Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis.  Multiple Sclerosis Journal, 23:721-733.

Motl RW, Cohen JA, Benedict RHB, Phillips G, LaRocca N, Hudson LD, Rudick R, and the Multiple Sclerosis Outcomes Assessment Consortium.  (2017).  Validity of the Timed 25-Foot Walk as an ambulatory performance outcome measure for multiple sclerosis.  Multiple Sclerosis Journal, 23:704-710.

Feys P, Lamers I, Francis G, Benedict RHB, Phillips G, LaRocca N, Hudson LD, Rudick R, and the Multiple Sclerosis Outcomes Assessment Consortium.  (2017).  The Nine-Hole Peg Test as a manual dexterity performance measure for multiple sclerosis.  Multiple Sclerosis Journal, 23:711-720.

Balcer LJ, Raynowska J, Nolan R, Galetta SL, Kapoor R, Benedict RHB, Phillips G, LaRocca N, Hudson LD, Rudick R, and the Multiple Sclerosis Outcomes Assessment Consortium.  (2017).  Validity of Low-Contrast Letter Acuity as a visual performance outcome measure for multiple sclerosis.  Multiple Sclerosis Journal, 23:734-747.

Roy S, Schwartz CE, Duberstein P, Dwyer MG, Zivadinov R, Bergsland N, Powell V, Weinstock-Guttman B, Benedict RHB.  (2016).  Synergistic Effects of Reserve and Adaptive Personality in Multiple Sclerosis.  Journal of the International Neuropsychological Society, 22:1-8.

Frndak SE, Irwin L, Kordovski V, Milleville K, Fisher C, Drake AS, Benedict RHB.  (2015).  Negative work events reported online precede job loss in multiple sclerosis.  Journal of the Neurological Sciences, 357:209-214.

Benedict RHB, Rodgers JDP, Emmert NUG, Kininger R, Weinstock-Guttman B.  (2014).  Negative work events and accommodations in employed multiple sclerosis patients.  Multiple Sclerosis Journal, 20:116-119.

Benedict RHB, Hulst HE, Bergsland N, Schoonheim MM, Dwyer MG, Weinstock-Guttman B, Geurts J, Zivadinov R (2013).  Clinical significance of atrophy and white matter mean diffusivity within the thalamus of multiple sclerosis patients.   Multiple Sclerosis Journal, 19:1478-1484.

Benedict RHB, Smerbeck AP, Parikh R, Rodgers JP, Cadavid D Erlanger D (2012).  Reliability and equivalence of alternate forms for the Symbol Digit Modalities Test: Implications for multiple sclerosis clinical trials.  Multiple Sclerosis Journal, 18:1320-1325.

Benedict RHB, Walton M.  (2012).  Evaluating cognitive outcome measures in MS clinical trials: What is a clinically meaningful change?  Multiple Sclerosis Journal, 18:1673-1679.

Benedict RHB, Amato MP, Boringa J, Brochet B, Foley F, Fredrikson S, Hamailainen P, Hartung HP, Krupp L, Penner IK, Reder AT, Langdon DW (2012).  Brief International Cognitive Assessment for MS (BICAMS): International standards for validation.  BMC Neurology, volume 12, article 55.

Benedict RHB, Morrow SP, Rodgers JP, Hojnacki D, Bucello MA, Zivadinov R, Weinstock-Guttman B.  (2014).  Characterizing cognitive function during relapse in multiple sclerosis.  Multiple Sclerosis Journal, 20:1745-1752.

Langdon DW, Amato MP, Boringa J, Brochet B, Foley F, Fredrikson S, Hamailainen P, Hartung HP, Krupp L, Penner IK, Reder AT, Benedict RHB (2012).  Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS).  Multiple Sclerosis Journal, 18:891-898.